DANNY ROELFS: Open Payments
NPI 1255666111 · NORTH PLATTE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 22 payments from 10 companies in 2025. Trend: 2023 $665 · 2024 $520 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $124 |
| ABBVIE INC. | 4 | $93 |
| Janssen Biotech, Inc. | 3 | $61 |
| UCB, Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Lilly USA, LLC | 1 | $25 |
| Amgen Inc. | 1 | $23 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $13 |
Products named: COSENTYX, RINVOQ, TREMFYA, Bimzelx, DUPIXENT, NEMLUVIO, SKYRIZI, TALTZ.
Industry payments across NE — which companies pay providers there.
